a Bayesian reanalysis combining past and current evidence from different clinical trials about single agent Trastuzumab or Lapatinib treatment ofr HER2-overexpressing breast cancer
Single agent Trastuzumab or Lapatinib to treat HER2-overexpressing breast cancer: combining past and current evidence in a Bayesian reanalysis / Giuseppe de Vito, Ileana Baldi, Annamaria Nuzzo, Filippo Montemurro, Paola Berchialla. - In: TRIALS. - ISSN 1745-6215. - ELETTRONICO. - 18:(2017), pp. 200-200. ( 38 th Annual Meeting of the Society for Clinical Trials Liverpool, United Kingdom. ) [10.1186/s13063-017-1902-y].
Single agent Trastuzumab or Lapatinib to treat HER2-overexpressing breast cancer: combining past and current evidence in a Bayesian reanalysis
Giuseppe de Vito;
2017
Abstract
a Bayesian reanalysis combining past and current evidence from different clinical trials about single agent Trastuzumab or Lapatinib treatment ofr HER2-overexpressing breast cancer
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
document.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
3.98 MB
Formato
Adobe PDF
|
3.98 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
